ArticleJournal of clinical biochemistry and nutrition2025
Analysis of autonomic function in patients with functional dyspepsia using real-time wearable devices and smartphone applications.
Article in Journal of clinical biochemistry and nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Diagnosis of Functional Dyspepsia and Novel Gastrointestinal Functional Assessments.Digestion · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Autonomic dysfunction is involved in functional dyspepsia (FD) however, the details have not been elucidated. The aim is to clarify the relationship among autonomic nervous system (ANS) activity, life events, and abdominal symptoms by real-time recordings. This is a prospective multicenter study including 9 patients with FD and 23 healthy controls (HC). The ANS activity was recorded for 24 h using a T-shirt-type wearable device. Life events and abdominal symptoms were simultaneously recorded with ANS activity by smartphone application software. We defined low-frequency/high-frequency (LF/HF) and HF as activity indicators of the sympathetic and parasympathetic nerves, respectively. The number of abnormal LF/HF and HF in patients with FD was significantly higher than that in HC. The number of abnormal LF/HF and HF signals was significantly positively correlated with dyspeptic symptoms. The number of abnormal LF/HF signals was significantly negatively correlated with quality of life (QOL). During the symptomatic period, the HF levels were elevated in the HC group. In contrast, HF significantly decreased in patients with FD, which may imply parasympathetic nervous system dysfunction. In conclusion, patients with FD have abnormal ANS activity, which is associated with symptoms and lower QOL, and they exhibit parasympathetic nervous system dysfunction during symptomatic period.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.